Finding Vredo: The Dutch Supreme Court Decision on Escitalopram
Abstract
This article is about the pharma patent litigation sparked by Lundbeck's blockbuster drug for 'escitalopram', a drug used for treating depression and generalized anxiety disorder. The key theme is about whether patents can also protect novel substances that can be fully envisaged but cannot yet be made. The decision of the Supreme Court is compared with earlier decisions in Germany and the United Kingdom. The author criticizes the lack of explanation provided by the Supreme Court.
Industriële eigendom, Octrooirecht
Bibtex
Article{nokey,
title = {Finding Vredo: The Dutch Supreme Court Decision on Escitalopram},
author = {Tsoutsanis, A.},
url = {http://ssrn.com/abstract=2451438},
year = {0718},
date = {2014-07-18},
journal = {Berichten Industriële Eigendom},
number = {2},
abstract = {This article is about the pharma patent litigation sparked by Lundbeck's blockbuster drug for 'escitalopram', a drug used for treating depression and generalized anxiety disorder. The key theme is about whether patents can also protect novel substances that can be fully envisaged but cannot yet be made. The decision of the Supreme Court is compared with earlier decisions in Germany and the United Kingdom. The author criticizes the lack of explanation provided by the Supreme Court.},
keywords = {Industriële eigendom, Octrooirecht},
}